Condition
Prostate
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 20 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
20 shownPhase I Study of SYS6043 in Patients With Advanced/Metastatic Solid TumorsNCT07424547 · 2026-03-03
RECRUITINGPOSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 LesionsNCT07220720 · 2025-11-04
RECRUITINGCollection of Blood From Patients With Prostate CancerNCT00923221 · 2007-02-28
RECRUITINGEfficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer.NCT07730151 · 2026-08-01
NOT_YET_RECRUITINGFocal Therapy in Localized Prostate Cancer: a Prospective RegistryNCT06772116 · 2025-02-01
NOT_YET_RECRUITINGOtago Exercises on the Risk of Falling in Prostatic Cancer Patients Receiving Androgen Deprivation TherapyNCT06605846 · 2024-09-23
COMPLETEDComparison of the Integrated Posterior-Anterior-Lateral Approach and the Posterior Approach in Robotic Radical ProstatectomyNCT07305142 · 2024-05-16
COMPLETEDDose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) DeviceNCT06192758 · 2024-04-15
ACTIVE_NOT_RECRUITINGSynthetic Metabolic and Genetic Networks for Medical DiagnosicsNCT04518072 · 2021-01-06
TERMINATEDOlaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker AnalysisNCT03047135 · 2017-03-01
ACTIVE_NOT_RECRUITINGEducational Intervention in Increasing Knowledge About Prostate Cancer in High-Risk NeighborhoodsNCT03197896 · 2016-09-29
COMPLETEDElectronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing TreatmentNCT03197948 · 2016-07-28
TERMINATEDVirtual Reality Education Module in Reducing Anxiety and Increasing Knowledge in Patients With Prostate Cancer Undergoing Radiation TherapyNCT03318367 · 2014-08-06
TERMINATEDOpen Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation PatsNCT01078662 · 2010-02-21
COMPLETEDSafety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.NCT00423254 · 2007-02-01
COMPLETEDImpact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.NCT00364455 · 2002-12-01
COMPLETEDRapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's CycleNCT00586898 · 2001-07-01
COMPLETEDMultivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate CancerNCT00579423 · 2000-11-01
COMPLETEDEvaluation for NCI Radiation Oncology Branch Clinical Research ProtocolsNCT00026689 · 2000-09-11
COMPLETEDExpanded Access 68Gallium-PSMA-11 PET for Prostate CancerNCT04377152
APPROVED_FOR_MARKETINGCommon interventions
Educational InterventionOTHER2OlaparibDRUG268Gallium-PSMA-11DRUG1ADTDRUG1BicalutamideDRUG1Blood sample (1 EDTA tube, 1 SST tube, 1 Streck tube) and urine sample (100 ml)OTHER1DarolutamideDRUG1docetaxelDRUG1Epoetin alfaDRUG1Estrogen transdermal patchDRUG1Flotufolastat F 18DRUG1Focal TherapyPROCEDURE1GnRHDRUG1Internet-Based InterventionOTHER1KetoconazoleDRUG1Medical ADT treatmentOTHER1otago excercisesOTHER1PAL combined approach groupPROCEDURE1Positron Emission Tomography (PET)PROCEDURE1posterior approach groupPROCEDURE1PSMA/PRAMEBIOLOGICAL1QS21BIOLOGICAL1SYS6043DRUG1Testosterone transdermal gelDRUG1TheraSphere PCaDEVICE1
Leading sponsors
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
3
Memorial Sloan Kettering Cancer Center
2
National Cancer Institute (NCI)
2
AstraZeneca
1
Boston Scientific Corporation
1
Conjupro Biotherapeutics, Inc.
1
Institut Mutualiste Montsouris
1
Janssen-Ortho Inc., Canada
1
Mannkind Corporation
1
MTI University
1
RenJi Hospital
1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1
The First Affiliated Hospital of Zhengzhou University
1
University Hospital, Montpellier
1
University of California, San Francisco
1
Trial status mix
COMPLETED9
RECRUITING3
TERMINATED3
ACTIVE_NOT_RECRUITING2
NOT_YET_RECRUITING2
APPROVED_FOR_MARKETING1
Phase mix
PHASE26
NA5
PHASE12
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.